A Novel Theranostic Strategy for Malignant Pulmonary Nodules by Targeted CECAM6 with <sup>89</sup>Zr/<sup>131</sup>I-Labeled Tinurilimab.

Adv Sci (Weinh) · 2025 · PMC12140296 · PMID 40178153

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Further clinical evaluation and translation of this CEACAM6‐targeted theranostics may be significant help in diagnosis and treatment of LUAD.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

A Novel Theranostic Strategy for Malignant Pulmonary Nodules by Targeted CECAM6 with &lt;sup&gt;89&lt;/sup&gt;Zr/&lt;sup&gt;131&lt;/sup&gt;I-Labeled Tinurilimab.

The sentences

A Novel Theranostic Strategy for Malignant Pulmonary Nodules by Targeted CECAM6 with <sup>89</sup>Zr/<sup>131</sup>I-Labeled Tinurilimab.